HAIFA, ISRAEL / ACCESS Newswire / November 19, 2025 / NDS Deutschland and EuroTrophy (the European hub for TROPHY APS developed by RAFAEL Advanced Defense System Ltd.) declare the completion of the successful integration of the Trophy® Active Protection System (APS) onto the BOXER Armored Personnel Carrier (APC). Following a joint industry initiative, the two companies had recently completed the integration of the Trophy® APS on a first pre-serial prototype BOXER in an APC configuration.
The engineering efforts included design reviews, surveys and adaptation work to a first of its kind BOXER Mission Module, to be able to carry the APS and enable the full scale of its capabilities. Most recently, the integration was completed by successfully conducting all system tests on the platform, including calibration of the APS, thus making it ready for live firing.
As a result of the successful integration and the creation of a first prototype, the companies also announce that a series of live firing tests will be conducted in Germany during the upcoming months. This will serve as a ‘risk mitigation’ activity for all current and future BOXER users who are currently seeking to enhance the protection capabilities of their platforms.
The BOXER is one of the world’s leading 8X8 Armored Fighting Vehicles, and offers unmatched modularity.
The first of its kind integration of a mature and combat proven APS, makes it combat ready, and enables unparalleled protection from ATGMs, RPGs, drones and other ‘Anti-Tank’ threats.
Ralf Ketzel, CEO of KNDS Deutschland, had stated: “With the successful integration of the Trophy® system on Boxer the three Companies EuroTrophy, Rafael and KNDS continue the way started with the LEOPARD 2 A8 to provide advanced technology to protect the lives of soldiers.”
Meir Ben-Tzook, Chairman of the Board at EuroTrophy added: “These integration efforts between the BOXER and Trophy® stems from a deep understanding that the mission of the BOXER had changed profoundly, it will now have to be used in the frontlines, where Trophy’s capabilities play a major role. We are pleased with the progress of the activity so far and are looking forward to continue the good cooperation with all parties involved.”
Tucson, AZ November 18, 2025 –(PR.com)– Many people love the look of custom homes, but underestimate the process of creating one. “There are 1,000 decisions you don’t even know you have to make,” says Maya Axt of Maya Axt Interiors, an Arizona-based interior design studio. “And if you make a choice you regret, you either have to live with it or pay to have it fixed.”
That’s why Axt emphasizes the importance of having a designer involved from the earliest planning stages of construction—and why she’s launching a design-build service specifically for new builds in Tucson.
Homeowners who take advantage of this service benefit from Axt’s established network of trusted contractors and artisans, ensuring quality craftsmanship and a unified, start-to-finish project management approach. Involving an interior designer early in the project also leads to more intuitive floor plans and opportunities for personalization. “Designers are on-site advocates for homeowners,” Axt explains. “But getting it right the first time saves builders time and money, too.”
Axt says the new service launch is part of her broader mission to take the stress out of bespoke construction. “It can be nerve-wracking to not have eyes and ears on the job site, especially for clients who don’t yet live in the area,” she adds. The new design-build offering bridges that gap, providing homeowners with a partner who speaks the language of the trades, knows their style, and prioritizes their interests from day one.
The one-night event, called “Hope for America,” aimed to bring hope to a community shocked by Charlie Kirk’s assassination
OREM, UT / ACCESS Newswire / November 18, 2025 / Thousands gathered at Utah Valley University’s UCCU Center for an unforgettable evening of worship, inspiration and community during the latest Harvest Crusade hosted by Pastor Greg Laurie. The one-night event, themed “Hope for America,” featured powerful performances from award-winning Christian artists Chris Tomlin and Phil Wickham.
Pastor Greg Laurie Greg Laurie stands behind the pulpit at the Harvest Crusade: Hope for America at Utah Valley University
Originally planned for 2027, the Harvest Crusade was hastened by the tragic Sept. 10 assassination of Charlie Kirk on the campus of Utah Valley University. “When we heard of Charlie Kirk’s assassination,” Laurie said, “we immediately reached out to pastors in Utah to ask how we could support them. They said, ‘Come sooner. Our community is hurting.’”
The Harvest Crusade brought together attendees from across the region, as well as 1000 volunteers, with 67 churches in surrounding areas serving as remote overflow sites. In addition, hundreds of media partners streamed the event nationally, including over 600 radio stations.
The evening opened with a moving tribute video honoring the life and legacy of Charlie Kirk, setting the tone for a night centered on hope and bold faith.
“Despite this tragedy, God has done amazing things around our nation and people are asking questions. . . . It was like a wakeup call,” Laurie said. “This is your moment tonight. This is your wakeup call tonight. Don’t let it slip by.”
The event concluded with an invitation for attendees to make a personal commitment to faith as artist Phil Wickham sang “Oh Come to the Altar.” By the end of the evening, over 2,100 people had made professions of faith in person and online.
“I was there at UVU on [Sept. 10] and witnessed the murder,” said one attendee. “Seeing the UCCU arena filled with people who were hungry to heal was amazing. The altar call broke me with joyful tears… Healed and peaceful are two words I now identify with.”
Event Highlights:
Venue Attendance: 7,800
Livestream Views: 210,000
Professions of Faith: 2,100+
Participating churches: 67
“Our one-night event at UVU in Utah was an astounding success! The people were so open, worshipful, and responsive to the gospel. Many came to Christ,” Laurie said.
The Harvest Crusade at Utah Valley University marks another milestone in Pastor Greg Laurie’s over-35-year ministry of large-scale evangelistic events. Harvest Crusades are large-scale evangelistic events with a worldwide history spanning the United States, Canada, New Zealand and Australia. Since 1990, more than six million people have attended Harvest Crusades in person, in addition to the millions more that have participated online. Cumulatively, more than 600,000 individuals have made professions of faith through the Harvest Crusades.
MEDIA: High-quality photos of the Harvest Crusade are available here.
For more information about upcoming Harvest events, visit https://harvest.org.
Greg Laurie is the founder of the Harvest Crusades and senior pastor of Harvest Church, with campuses located in California and Hawaii. He is a renowned evangelist, bestselling author and inspiration for the 2023 “Jesus Revolution” film. He leads annual Harvest Crusades, large-scale evangelistic events that share the gospel with thousands in stadiums worldwide.
REGINA, SK / ACCESS Newswire / November 18, 2025 / Eastside Audiology & Rehabilitation has once again been recognized with the 2025 Consumer Choice Award in the Hearing Services category for Regina. This year marks the clinic’s 10th consecutive win, highlighting a decade of dedication to patient care, innovation, and community trust.
Since its founding, Eastside Audiology has set itself apart from other hearing clinics by removing the pressure often associated with purchasing hearing aids. Patients can expect an honest, supportive environment where their needs come first.
“We know that people have had negative experiences elsewhere where the pressure to buy felt overwhelming,” says the Eastside Audiology team. “At Eastside, that will never happen. Our focus is on providing exceptional diagnostic care, offering solutions tailored to each patient, and ensuring people feel confident about their hearing health.”
Comprehensive Care for All Ages
Eastside Audiology is proud to be an innovative diagnostic audiology clinic, equipped with advanced technology and staffed by a highly trained team. Their professionals include Doctors of Audiology, Audiologists, and Hearing Aid Practitioners, enabling them to provide comprehensive hearing assessments and rehabilitation services.
From paediatric to geriatric patients, Eastside Audiology has the expertise to serve clients of all ages with compassion and precision.
Recognition Rooted in Community Trust
The Consumer Choice Award is the only organisation in North America that recognizes business excellence based solely on the opinions of consumers. Winners are determined through an independent research process that evaluates reputation, customer satisfaction, and overall excellence.
For Eastside Audiology, earning the award for 10 consecutive years reflects both the loyalty of its patients and the trust it has built across the Regina community.
“This recognition is so meaningful because it comes directly from the people we serve,” the team adds. “It inspires us to continue raising the standard for hearing care in Saskatchewan.”
A Decade of Excellence, A Future of Innovation
As Eastside Audiology celebrates its 10th Consumer Choice Award, the clinic remains committed to evolving with the latest advancements in hearing technology and rehabilitation. Their mission is to ensure every patient can experience life with sound without pressure, without compromise, and with the highest level of care.
To learn more about Eastside Audiology & Rehabilitation or to book an appointment, visit www.lifewithsound.com.
About Eastside Audiology & Rehabilitation
Eastside Audiology & Rehabilitation is an award-winning diagnostic audiology clinic in Regina, Saskatchewan. For more than a decade, the clinic has provided comprehensive hearing services for patients of all ages, from children to seniors. Staffed by Doctors of Audiology, Audiologists, and Hearing Aid Practitioners, Eastside Audiology offers advanced testing, personalized rehabilitation, and a patient-first approach that prioritizes trust and care. Learn more at www.lifewithsound.com.
About Consumer Choice Award
Consumer Choice Award has been recognizing and promoting business excellence in North America since 1987. Its rigorous selection process ensures that only the most outstanding service providers in each category earn this prestigious recognition. Visit www.ccaward.com to learn more.
Contact Information Sumi Saleh Communications Manager ssaleh@ccaward.com
New capabilities strengthen U.S. production, completing Moderna’s domestic end-to-end mRNA manufacturing network
More than $140 million investment will create hundreds of highly skilled biomanufacturing jobs
CAMBRIDGE, MA / ACCESS Newswire / November 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced the expansion of its U.S. manufacturing capabilities with the onshoring of Drug Product manufacturing to its existing Moderna Technology Center (“MTC”) in Norwood, Massachusetts. Through this strategic onshoring, Moderna will now operate full end-to-end manufacturing for its mRNA medicines in the U.S. This milestone marks a significant step in strengthening Moderna’s U.S. manufacturing network, supporting both commercial and clinical supply, and reinforcing the Company’s commitment to domestic mRNA production.
“By onshoring Drug Product manufacturing to our campus in Norwood, Massachusetts, we have completed the full manufacturing loop under one roof in the U.S.,” said Stéphane Bancel, Chief Executive Officer of Moderna. “As an American company committed to building and producing in America, we are proud to strengthen our domestic footprint while bringing meaningful new jobs to the community.”
The expansion reflects Moderna’s ongoing investment in U.S.-based infrastructure and its commitment to build a robust, domestic manufacturing platform capable of supporting its pipeline of mRNA vaccines and therapeutics. Moderna’s innovative mRNA platform, first widely recognized globally during the Company’s partnership with the U.S. Government through Operation Warp Speed, continues to drive potential biomedical breakthroughs across infectious diseases, cancer, rare diseases and autoimmune disorders.
Construction at MTC for the new Drug Product manufacturing capability has started with Moderna targeting completion by the first half of 2027.
About Moderna Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna’s mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company’s values and mindsets, Moderna’s mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: Moderna’s U.S. manufacturing network and ongoing investment in U.S.-based infrastructure; the potential of Moderna’s mRNA platform; Moderna’s targeted completion of its new Drug Product manufacturing capability by the first half of 2027; and expected job creation. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in subsequent filings made by Moderna with the U.S. Securities and Exchange Commission, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.
Moderna Contacts Media: Chris Ridley Head of Global Media Relations +1 617-800-3651 Chris.Ridley@modernatx.com
Investors: Lavina Talukdar Senior Vice President & Head of Investor Relations +1 617-209-5834 Lavina.Talukdar@modernatx.com
Optimizes Capital Structure and Financial Flexibility
VANCOUVER, BC AND BREDA, NETHERLANDS / ACCESS Newswire / November 17, 2025 / Organto Foods Inc. (TSX-V:OGO)(OTCQX:OGOFF)(FSE:OGF0) (“Organto” or the “Company”), is pleased to announce that it has completed the previously announced prepayment of all outstanding 10% convertible notes totaling CDN $2,340,850, as part of the Company’s ongoing efforts to optimize its capital structure and position for anticipated growth.
As previously announced on October 24, 2025, the Company provided 30 days’ notice to holders of the convertible notes of its intention to prepay the outstanding notes, including all interest accrued through November 24, 2025. During the notice period, debenture holders had the option to convert their notes at a conversion price of $0.60 per common share; however, 100% of holders elected to receive a cash payment in lieu of conversion. As a result, the Company has repaid principal of CDN $2,340,850 plus accrued interest of $206,829 to note holders.
The prepaid convertible notes were originally scheduled to mature in tranches through March 2027, with $922,000 due in December 2025 and $148,000 due in February 2026, followed by additional maturities in December 2026, February 2027, and March 2027. These debentures were convertible into common shares at a conversion price of $0.60 per common share and could have been force-converted if the Company’s stock traded at or above $0.90 per share for a period of ten consecutive trading days.
“The proactive prepayment of these convertible notes is a key part of our broader financing strategy,” said Steve Bromley, Co-Chair and CEO of Organto Foods Inc. “By removing the potential dilution and debt service costs related to these convertible securities, we believe we are positioning our business for greater flexibility and improved cash flow as we execute on plans to continue to advance our global organic and fairtrade foods platform. This action reflects our confidence in our business, our commitment to sustainable growth, and our focus on the creation of long-term shareholder value.”
ON BEHALF OF THE BOARD
Steve Bromley Co-Chair and CEO For more information, contact:
John Rathwell, Senior Vice President Corporate Development 647 629 0018 info@organto.com
ABOUT ORGANTO
Organto is an integrated provider of branded, private label, and distributed organic, fairtrade and non-GMO fruit and vegetable products using a strategic asset-efficient business model to serve a growing socially responsible and health-conscious consumer around the globe. Organto’s business model is rooted in its commitment to sustainable business practices focused on environmental responsibility and a commitment to the communities where it operates, its people, and its shareholders.
FORWARD LOOKING STATEMENTS
This news release may include certain forward-looking information and statements, as defined by law, including, without limitation, Canadian securities laws and the “safe harbor” provisions of the US Private Securities Litigation Reform Act (“forward-looking statements”). In particular, and without limitation, this news release contains forward-looking statements respecting the completion of the prepayment of the Convertible notes and accrued interest; Organto’s belief that by removing the potential dilution and debt service costs related to these convertible securities, the Company is better positioned for greater flexibility and improved cash flow as it executes on plans to continue to advance its global organic and fairtrade foods platform; and Organto’s belief that this action reflects its confidence in its business, its commitment to sustainable growth, its focus on the creation of long-term shareholder value. . Forward-looking statements are based on several assumptions that may prove to be incorrect, including, without limitation, the assumption that the timing and completion of the prepayment of the Convertible Notes (including payment of principal and interest), the anticipated elimination of dilution risk, the expectation that the remaining debt will be fully discharged by year-end. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Factors that could cause actual results to differ materially from those anticipated in forward-looking statements in this news release include, among others, regulatory risks including related to market volatility and economic conditions; risks related to unforeseen delays; and risks that necessary financing will be unavailable when needed. For further information on these and other risks and uncertainties that may affect the Company’s business, see the “Risks and Uncertainties” and “Forward-Looking Statements” sections of the Company’s annual and interim management’s discussion and analysis filings with the Canadian securities regulators, which are available under the Company’s profile at www.sedarplus.ca. Except as required by law, Organto does not assume any obligation to release publicly any revisions to forward-looking statements contained in this news release to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
SAN BERNARDINO, CALIFORNIA / ACCESS Newswire / November 18, 2025 / Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF)(FSE:YE1) is pleased to announce that recent drilling at its 100%-owned Colosseum Gold and Rare Earth Element (REE) Project in San Bernardino County, California has returned encouraging gold assay results that align with the Company’s expectations and confirm the continuity of mineralisation within the existing open-pit mineral resource. These results strongly support the Company’s strategy to convert Inferred Mineral Resources to the higher confidence Measured and Indicated categories, thereby upgrading the JORC-2012 mineral resource as part of the ongoing feasibility work.
Highlights
Strong gold intercepts from infill drillingconfirm the continuity of mineralisation at depth:
RC25-020 returned 85.34m @ 1.33 g/t Au (beneath the existing pit) and,
CM25-19 returned 61.26m @ 1.18 g/t Au (partial result; remaining assays pending),
Assays received in line with expectations and demonstrate consistent grades over broad intervals, supporting the geological model.
Expanded M&I mineral resource to strengthen Feasibility Study: A larger high-confidence (M&I) resource base will underpin the Bankable Feasibility Study (BFS), enhancing mine design and economic robustness.
The standout drilling intercepts include 85.34 metres at 1.33 g/t Aufrom RC25-020, a reverse-circulation hole drilled beneath the current pit floor, and 61.26 metres at 1.18 g/t Aufrom CM25-19 (a diamond core hole for which assays are still pending beyond this interval). Hole RC25-020’s long intercept of consistent gold grades indicates a continuation of the gold mineralisation below the mined pit, extending the known mineralised envelope at depth. Hole CM25-19, an infill hole targeting a previously sparsely drilled zone, has already delivered a substantial gold interval in its upper section.
The breadth and grade of these intersections are comparable to the deposit’s average mineral resource grade, reinforcing confidence that the geological model is accurate and that gold mineralisation persists as predicted.
Figure 1: Cross-section of the Colosseum deposit illustrating the existing open pit outline and gold mineralized breccia pipe (blue modelled mineral resource zones). The approximate positions of key new drill intercepts (e.g., RC25-020 and CM25-19) are highlighted below the current pit. These results demonstrate the extension of gold mineralization at depth beneath the pit, supporting the planned upgrade of Inferred resources to higher-confidence categories.
The current JORC-2012 Mineral Resource for the Colosseum Gold deposit stands at 27.1 million tonnes @ 1.26 g/t Au for 1.1 million ounces of gold. Approximately 67% of this resource is classified as Measured and Indicated, with the remaining 33% classified as Inferred. The completed infill drilling program focused on upgrading the Inferred resource by increasing drill density in those areas and confirming grade continuity. The latest batch of results provides clear evidence that a significant portion of the previously Inferred material can be elevated to higher confidence categories, as the intercepted grades and thicknesses are consistent with the current mineral resource model.
In summary, the latest drill results from Colosseum are in line with expectations and confirm the robustness of the geological model. They substantiate the Company’s approach to upgrade the mineral resource classification, thereby increasing the proportion of gold ounces in the Measured and Indicated categories. This will provide a stronger foundation for mine development plans and improve the quality of the BFS.
Dateline will continue to update shareholders as additional assay results are received and as the JORC mineral resource update process progresses. The Company is confident that the ongoing drilling will add tangible value to the Colosseum Gold-REE Project by enhancing the mineral resource base and de-risking the path to production.
This press release has been authorized for release by the Board of Dateline Resources Limited.
For more information, please contact:
Stephen Baghdadi Managing Director +61 2 9375 2353
Follow Dateline on socials: X – @Dateline_DTR Truth Social – @dateline_resources LinkedIn – dateline-resources
About Dateline Resources Limited
Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF)(FSE:YE1.F) is an Australian company focused on mining and exploration in North America. The Company owns 100% of the Colosseum Gold-REE Project in California.
The Colosseum Gold Mine is located in the Walker Lane Trend in East San Bernardino County, California. On 6 June 2024, the Company announced to the ASX that the Colosseum Gold mine has a JORC-2012 compliant Mineral Resource estimate of 27.1Mt @ 1.26g/t Au for 1.1Moz. Of the total Mineral Resource, 455koz @ 1.47/t Au (41%) are classified as Measured, 281koz @1.21g/t Au (26%) as Indicated and 364koz @ 1.10g/t Au (33%) as Inferred.
On 23 May 2025, Dateline announced that updated economics for the Colosseum Gold Project generated an NPV6.5 of US$550 million and an IRR of 61% using a gold price of US$2,900/oz.
The Colosseum is located less than 10km north of the Mountain Pass Rare Earth mine. Planning has commenced on drill testing the REE potential at Colosseum.
Dateline has also acquired the high-grade Argos Strontium Project, also located in San Bernadino County, California. Argos is reportedly the largest strontium deposit in the U.S. with previous celestite production grading 95%+ SrSO4.
Forward-Looking Statements
This announcement may contain “forward-looking statements” concerning Dateline Resources that are subject to risks and uncertainties. Generally, the words “will”, “may”, “should”, “continue”, “believes”, “expects”, “intends”, “anticipates” or similar expressions identify forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Many of these risks and uncertainties relate to factors that are beyond Dateline Resources’ ability to control or estimate precisely, such as future market conditions, changes in regulatory environment and the behavior of other market participants. Dateline Resources cannot give any assurance that such forward-looking statements will prove to have been correct. The reader is cautioned not to place undue reliance on these forward-looking statements. Dateline Resources assumes no obligation and does not undertake any obligation to update or revise publicly any of the forward-looking statements set out herein, whether as a result of new information, future events or otherwise, except to the extent legally required.
Competent Person Statement
Sample preparation and any exploration information in this announcement is based upon work reviewed by Mr Greg Hall who is a Chartered Professional of the Australasian Institute of Mining and Metallurgy (CP-IMM). Mr Hall has sufficient experience that is relevant to the style of mineralization and type of deposit under consideration and to the activity which he is undertaking to qualify as a Competent Person as defined in the 2012 Edition of the “Australasian Code for Reporting Exploration Results, Mineral Resources and Ore Reserves” (JORC Code). Mr Hall is a Non-Executive Director of Dateline Resources Limited and consents to the inclusion in the report of the matters based on this information in the form and context in which it appears.
Company Confirmations
The Company confirms it is not aware of any new information or data that materially affects the information included in the announcements dated 23 October 2024 with regard to the Colosseum MRE and 23 May 2025 with regard to Colosseum Project Economics. Similarly, the Company confirms that all material assumptions and technical parameters underpinning the estimates and the forecast financial information referred to in those previous announcements continue to apply and have not materially changed.
MCLEAN, VA / ACCESS Newswire / November 17, 2025 / Gladstone Capital Corporation (Nasdaq:GLAD) (the “Company”) today announced earnings for its fourth quarter and fiscal year ended September 30, 2025. Please read the Company’s Annual Report on Form 10-K filed today with the U.S. Securities and Exchange Commission (the “SEC”), which is available on the SEC’s website at www.sec.gov and the Investors section of the Company’s website at www.GladstoneCapital.com.
Summary Information (dollars in thousands, except per share data) (unaudited):
For the Quarter Ended:
September 30,
2025
June 30,
2025
Change
% Change
Total investment income
$
23,936
$
21,657
$
2,279
10.5
%
Total expenses, net of credits
(12,492
)
(10,363
)
(2,129
)
20.5
Net investment income
11,444
11,294
150
1.3
Net investment income per common share
0.52
0.50
0.02
4.0
Cash distribution per common share
0.59
0.50
0.09
18.0
Net realized gain (loss)
(6,258
)
(3,620
)
(2,638
)
72.9
Net unrealized appreciation (depreciation)
9,101
15
9,086
NM
Net increase (decrease) in net assets resulting from operations
13,971
7,448
6,523
87.6
Weighted average yield on interest-bearing investments
12.5
%
12.8
%
(0.3
)%
(2.3
)
Total invested
$
126,633
$
72,952
$
53,681
73.6
Total repayments and net proceeds
23,495
82,205
(58,710
)
(71.4
)
As of:
September 30,
2025
June 30,
2025
Change
% Change
Total investments, at fair value
$
859,124
$
751,260
$
107,864
14.4
%
Fair value, as a percent of cost
98.0
%
96.6
%
1.4
%
1.4
Net asset value per common share
$
21.34
$
21.25
$
0.09
0.4
NM- not meaningful
For the Year Ended:
September 30, 2025
September 30,
2024
Change
% Change
Total investment income
$
89,122
$
96,621
$
(7,499
)
(7.8
)%
Total expenses, net of credits
(43,915
)
(50,562
)
(6,647
)
(13.1
)
Net investment income
45,207
46,059
(852
)
(1.8
)
Net investment income per common share
2.02
2.11
(0.09
)
(4.3
)
Cash distribution per common share
2.48
1.98
0.50
25.3
Net realized gain (loss)
55,642
5,959
49,683
NM
Net unrealized appreciation (depreciation)
(42,739
)
42,703
(85,442
)
NM
Net increase (decrease) in net assets resulting from operations
57,191
94,506
(37,315
)
(39.5
)
Weighted average yield on interest-bearing investments
12.7
%
13.9
%
(1.2
)%
(8.6
)
Total invested
$
396,796
$
177,649
$
219,147
123.4
Total repayments and proceeds
352,317
136,270
216,047
158.5
As of:
September 30, 2025
September 30,
2024
Change
% Change
Total investments, at fair value
$
859,124
$
796,260
$
62,864
7.9
%
Fair value as a percent of cost
98.0
%
103.3
%
(5.3
)%
(5.1
)
Net asset value per common share
$
21.34
$
21.18
$
0.16
0.8
NM- not meaningful
Fourth Fiscal Quarter 2025 Highlights:
Portfolio Activity: Invested $106.7 million in five new portfolio companies and $19.9 million in existing portfolio companies.
Portfolio Mix: Secured first lien assets continue to be over 70% of our debt investments, at cost.
Debt Issuance: Issued our 5.875% Convertible Notes, due 2030 (the “2030 Convertible Notes”), for gross proceeds of $149.5 million.
Fourth Fiscal Quarter 2025 Results:
Total investment income increased by $2.3 million, or 10.5%, for the quarter ended September 30, 2025, compared to the prior quarter ended June 30, 2025, driven primarily by a $2.9 million increase in interest income, quarter over quarter, partially offset by a $0.6 million decrease in other income. Interest income increased by $2.9 million, or 14.0%, quarter over quarter, primarily due to an increase in the weighted average principal balance of our interest-bearing investment portfolio to $752.0 million during the quarter ended September 30, 2025 as compared to $647.2 million during the quarter ended June 30, 2025. This increase was offset by a decrease in the weighted average yield to 12.5% during the quarter ended September 30, 2025 as compared to 12.8% during the quarter ended June 30, 2025. The decrease in other income was driven by decreases in dividend income and prepayment fee income quarter over quarter.
Total expenses increased by $2.1 million, or 20.5%, quarter over quarter, primarily due to a $1.3 million increase in interest expense and a $0.9 million increase in the net incentive fee quarter over quarter. The quarter over quarter increase in interest expense was driven by a $0.9 million increase in interest expense on our Credit Facility and a $0.5 million increase in interest expense on our notes payable. The $0.9 million increase in interest expense on our Credit Facility was driven by increased borrowings; the weighted average balance outstanding on our Credit Facility for the quarter ended September 30, 2025 was $74.3 million, as compared to $6.6 million for the quarter ended June 30, 2025, an increase of $67.7 million quarter over quarter. The $0.5 million increase in interest expense on our notes payable was driven by the issuance of the 2030 Convertible Notes in September 2025. The quarter over quarter increase in the net incentive fee was driven by decreased credits to the incentive fee. These increases were partially offset by a $0.4 million decrease in the net base management fee, driven by higher investment banking fee credits to the base management fee from increased deal originations.
Net investment income for the quarter ended September 30, 2025 was $11.4 million, or $0.52 per share.
The net increase in net assets resulting from operations was $14.0 million, or $0.63 per share, for the quarter ended September 30, 2025, compared to $7.4 million, or $0.33 per share, for the quarter ended June 30, 2025. The current quarter increase in net assets resulting from operations was primarily driven by $11.4 million of net investment income and $9.1 million of net unrealized appreciation during the quarter, partially offset by $6.3 million of net realized loss recognized during the quarter.
Fiscal Year Ended 2025 Results:
Total investment income during the years ended September 30, 2025 and 2024 was $89.1 million and $96.6 million, respectively. The year over year decrease was primarily due to a $6.0 million decrease in interest income and a $1.5 million decrease in other income. The decrease in interest income was driven by a decrease in the weighted average yield of our interest-bearing investment portfolio from 13.9% during the year ended September 30, 2024 to 12.7% during the year ended September 30, 2025. This decrease was partially offset by an increase in the weighted average principal balance of our interest-bearing investment portfolio of $15.6 million, or 2.3%, year over year. The decrease in other income was driven primarily by a decrease of $0.9 million in dividend income and a decrease of $0.4 million in success fees received.
Expenses, net of any non-contractual, unconditional and irrevocable credits to fees from the Adviser, decreased $6.6 million, or 13.1%, for the year ended September 30, 2025, as compared to the prior year. This decrease was primarily due to a $3.1 million decrease in the net incentive fee, a $2.4 million decrease in the net base management fee, and a $1.7 million decrease in interest expense.
Net investment income for the year ended September 30, 2025 was $45.2 million, a decrease of 1.8%, as compared to the prior year, or $2.02 per share.
The net increase in net assets resulting from operations was $57.2 million, or $2.56 per share, for the year ended September 30, 2025, compared to $94.5 million, or $4.34 per share, for the year ended September 30, 2024. The current year increase was driven by net investment income of $45.2 million and net realized gains of $55.6 million, partially offset by $42.7 million in net unrealized depreciation.
Subsequent Events: Subsequent to September 30, 2025, the following significant events occurred:
Portfolio Activity:
In October 2025, we invested $11.0 million in Total Access Elevator, LLC (“Total Access”), an existing portfolio company, through secured first lien debt. We also extended Total Access a new $9.85 million delayed draw term loan commitment, which was unfunded at close.
In October 2025, our $28.1 million debt investment in Leadpoint Business Services, LLC paid off at par. We also received a $0.3 million prepayment penalty in conjunction with the payoff.
In October 2025, the sale of our remaining common equity investment in Sokol and Company, LLC was completed, representing a return of our equity cost basis of $0.5 million and a realized gain of approximately $1.8 million.
In October 2025, our debt investment in Sea Link International IRB, Inc. (“Sea Link”) paid off at par. We also received a $0.2 million exit fee in conjunction with the payoff. We continue to hold common and preferred equity in Sea Link.
In November 2025, we invested $15.0 million in Turn Key Health Clinics, LLC, an existing portfolio company, through secured first lien debt.
In November 2025, we invested $26.6 million in Sicilian Oven Restaurants LLC through secured first lien debt and preferred equity.
Debt Redemption:
In October 2025, we voluntarily redeemed our 7.75% Notes, due 2028, with an aggregate principal amount of $57.0 million.
In October 2025, we voluntarily redeemed our 5.125% Notes, due 2026, with an aggregate principal amount of $150.0 million.
Distributions and Dividends Declared:
In October 2025, our Board of Directors declared the following distributions to common and preferred stockholders:
Record Date
Payment Date
Distribution per Common Share
October 24, 2025
October 31, 2025
$
0.15
November 17, 2025
November 26, 2025
0.15
December 22, 2025
December 31, 2025
0.15
Total for the Quarter
$
0.45
Record Date
Payment Date
Distribution per Series A Preferred Stock
October 27, 2025
November 5, 2025
$
0.130208
November 25, 2025
December 5, 2025
0.130208
December 29, 2025
January 5, 2026
0.130208
Total for the Quarter
$
0.390624
Comments from Gladstone Capital’s President, Bob Marcotte: “FY25 closed on a high note as our lower middle market investment focus produced over $100 million of net originations, and we reset near term maturities and increased our floating rate funding via the debt refinancing concluded shortly after 9/30. These actions combined with our modest leverage have positioned us well to deliver continued asset growth and sustain our net interest income in support of future shareholder distributions.”
Conference Call for Stockholders: The Company will hold its earnings release conference call on Tuesday, November 18, 2025, at 8:30 a.m. Eastern Time. Please call (866) 424-3437 to enter the conference call. An operator will monitor the call and set a queue for any questions. A replay of the conference call will be available through November 25, 2025. To hear the replay, please dial (877) 660-6853 and use playback conference number 13755536. The replay of the conference call will be available beginning approximately one hour after the call concludes. The live audio broadcast of the Company’s quarterly conference call will also be available online at www.GladstoneCapital.com. The event will be archived and available for replay on the investors section of the Company’s website.
About Gladstone Capital Corporation: Gladstone Capital Corporation is a publicly-traded business development company that invests in debt and equity securities, consisting primarily of secured first and second lien term loans to lower middle market businesses in the United States. Information on the business activities of Gladstone Capital and the other publicly-traded Gladstone funds can be found at www.GladstoneCompanies.com.
To obtain a paper copy of the Company’s most recent Form 10-K, please contact the Company at 1521 Westbranch Drive, Suite 100, McLean, VA 22102, ATTN: Investor Relations. The financial information above is not comprehensive and is without notes, so readers should obtain and carefully review the Company’s Form 10-K for the year ended September 30, 2025, including the notes to the consolidated financial statements contained therein.
The statements in this press release about future growth and shareholder returns are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements inherently involve certain risks and uncertainties in predicting future results and conditions. Although these statements are based on our current plans that are believed to be reasonable as of the date of this press release, a number of factors could cause actual results and conditions to differ materially from these forward-looking statements, including those factors described from time to time in our filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect any future events or otherwise, except as required by law.
SIOUX FALLS, SD / ACCESS Newswire / November 18, 2025 / Avel eCare announced a landmark achievement this week as its Specialty Clinic service line officially surpassed 100,000 patient encounters – marking a major milestone in the company’s mission to deliver equitable specialty care to rural, remote, and underserved communities across the United States.
Launched in 2017, Avel eCare Specialty Clinic provides virtual access to specialists in cardiology, psychiatry, dermatology, endocrinology, rheumatology, and more. The service has transformed access to care for thousands of patients in rural and underserved areas, helping health systems expand specialty access and improve outcomes through innovative virtual care delivery.
“Reaching 100,000 patient encounters represents far more than a number – it represents lives changed,” said Dr. Kelly Rhone, Chief Medical Officer at Avel eCare. “Each encounter is a moment where a patient receives timely, expert care that might otherwise have been out of reach. We’re honored to serve as a trusted partner for clinicians and patients across the country.”
Through Avel eCare Specialty Clinic, patients gain access to trusted specialists without leaving their local facilities, saving time, reducing costs, and improving outcomes. Hospitals and health systems benefit from expanded coverage, workforce stabilization, and real-time scheduling that helps reduce no-show rates.
Since its inception, Avel’s Specialty Clinic team has become a proof-of-concept for how the Virtual Health System can drive lasting health equity, delivering measurable improvements in access, satisfaction, and clinical outcomes:
100,000+ patient encounters delivered virtually
Five states served through long-term partnerships with Tribal Health organizations
Significant reductions in travel time and costs for rural patients
“This milestone demonstrates what’s possible when innovation meets compassion,” said Doug Duskin, Chief Executive Officer at Avel eCare. “We’ve shown that telemedicine isn’t just a backup option – it’s a proven, effective model of care that strengthens communities, supports clinicians, and saves lives.”
“Behind every one of those 100,000 encounters is a story of access, connection, and collaboration,” said Rachel Dybvig, MBA, Director of Avel eCare Specialty Clinic. “Our providers have built meaningful, ongoing relationships with patients who now have consistent access to specialty care – many for the first time in their lives. That’s the real impact of this milestone.”
Avel eCare’s Specialty Clinic remains committed to advancing equitable access to specialty care, with ongoing growth across new specialties and regions. The program continues to expand its impact through collaboration with hospitals, clinics, and health systems nationwide – redefining what’s possible in virtual clinical care.
About Avel eCare
Avel eCare is one of the nation’s longest-standing telemedicine providers and a pioneer in the development of the Virtual Health System model. For more than 30 years, Avel has delivered high-quality, technology-enabled care across a wide range of clinical specialties, including emergency and critical care, behavioral health, pharmacy, and specialty medicine. Guided by a mission to improve access, quality, and equity of care, Avel eCare continues to lead the way in transforming how healthcare is delivered, wherever patients and providers need support.
Contact:
Jessica Gaikowski, Director of Marketing & Communications media@avelecare.com | 605.606.0150
TORONTO, ON / ACCESS Newswire / November 18, 2025 / Nextech3D.ai (CSE:NTAR)(OTCQX:NEXCF)(FSE:1SS), an AI-first 3D modeling and event technology company, today announced major milestones across its unified event-tech platform, including accelerated integration of its newly acquired Eventdex registration system, expanded deployments of its AI matchmaking engine, and milestone production of 800 floor plans in 2025. Through its flagship Map D’s interactive floor plan management platform and Eventdex platforms, the company powers thousands of events annually, delivering interactive floor mapping, exhibitor management, registration, ticketing, mobile apps, AR navigation, and AI matchmaking.
Eventdex Integration Ahead of Schedule Following the recent acquisition of Eventdex, Nextech3D.ai has completed the first phase of technical integration between Eventdex and Map D, creating a unified event operations ecosystem.
Phase one milestones:
Shared user, event, and ticketing database
Synchronized registration, ticketing, and badge printing all in one solution.
Connected mobile app data feeds without wifi
Unified product bundle available to customers
“These achievements position Nextech3D.ai as one of the only companies offering a full, modern, end-to-end event technology suite,” said Evan Gappelberg, CEO.
AI Matchmaking Expansion and Algorithm Upgrades AI matchmaking continues to be one of the Company’s most sought-after premium modules. Recent updates include the rollout of Preference Scoring v2, featuring:
Enhanced ML attribute weighting
Real-time clustering of attendee behavior and interests
Deeper integration with registration flows for higher data capture
Eventdex AI Matchmaking uses proprietary machine-learning algorithms to intelligently connect attendees, exhibitors, and sponsors based on shared business interests and behavioral data. The technology is fully integrated with Nextech3D.ai’s event platform and its Blockchain Ticketing solution, creating a seamless workflow from registration to networking and analytics.
Key Highlights
YTD 2025 revenue for Eventdex AI Matchmaking, hitting $100,000 milestone.
Significant adoption by enterprise and association events globally
Higher average contract value (ACV) through bundled sales with registration, ticketing, and floor-mapping products
Scalable growth model reinforced by the upcoming 2026 Event Token launch, which will extend loyalty, access, and engagement across the entire Nextech3D.ai ecosystem
Achieves Milestone Production of 800 Interactive Floor Plans in 2025 Nextech3D.ai’s Map D division has reached a significant production milestone with 800 interactive event floor plans created in 2025, marking the Company’s highest annual output to date.
Interactive floor plans are one of the Company’s most widely adopted products, used by associations, trade shows, and conference organizers to sell exhibitor booths, manage event layouts, and drive sponsor visibility.
Financial implications of this milestone:
Creates a scalable recurring revenue base from annual event renewals
Drives high-margin SaaS revenue across mapping and exhibitor management
Provides a direct pipeline for cross-selling Eventdex registration, ticketing, and AI matchmaking
Strengthens customer stickiness and multi-year retention
“The production of 800 floor plans this year demonstrates the scale, demand, and operational efficiency of our event-technology platform,” said CEO Evan Gappelberg. “Every floor plan represents an entire event lifecycle where we can now sell multiple modules.”
Growing Momentum Heading Into 2026 Nextech3D.ai continues to demonstrate strong commercial traction:
Sequential quarterly revenue growth of ~20% as reported on October 30th, 2025.
Gross margins ~88% as reported on October 30th, 2025.
Increased demand for multi-product bundles registration + mapping + mobile + AI matchmaking + ticketing.
Expanding 2026 event pipeline across associations, trade shows, and corporate conferences
“Our team is executing at a very high level,” added Gappelberg. “With Eventdex integrated, AI matchmaking scaling, and blockchain ticketing advancing faster than expected, we believe Nextech3D.ai is entering a positive inflection point.”
A Unified Vision for 2026 and Beyond Nextech3D.ai is now positioned with a powerful combined platform, integrating:
AI
3D & spatial computing
Ticketing & registration
Event mapping
Blockchain
This positions the Company at the intersection of large global markets: event technology and digital ticketing, both undergoing major shifts.
Nextech3D.AI is pleased to announce that it has completed its previously announced issuance of an aggregate of 3,688,218 common shares at a deemed price of Cdn$0.19 per share in consideration of past services.
The shares are subject to a four month hold period in accordance with the policies of the Canadian Securities Exchange.
This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act“) or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.
About Nextech3D.ai Nextech3D.ai (CSE:NTAR)(OTCQX:NEXCF)(FSE:1SS) is an AI-first technology company developing advanced 3D modeling, spatial computing solutions, and full-stack event technology, including AI matchmaking, interactive mapping, registration, and blockchain-powered ticketing.
Through its flagship Map D’s interactive floor plan management platform and Eventdex platforms, the company powers thousands of events annually, delivering interactive floor mapping, exhibitor management, registration, ticketing, mobile apps, AR navigation, and AI matchmaking.
Evan Gappelberg /CEO and Director 866-ARITIZE (274-8493)
Forward-looking Statements The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. Certain information contained herein may constitute “forward-looking information” under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as, “will be” or variations of such words and phrases or statements that certain actions, events or results “will” occur. Forward-looking statements regarding the completion of the transaction are subject to known and unknown risks, uncertainties and other factors. There can be no assurance that such statements will prove to be accurate, as future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Nextech will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.
